Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile

Jean Camille Mattei, Carine Jiguet‐Jiglaire|Cancers|2020

Cited by 12